Emory University School of Medicine - Winship Cancer Institute — Atlanta, Georgia

Public research footprint of Emory University School of Medicine - Winship Cancer Institute, compiled from the ClinicalTrials.gov public registry.

Registered studies

Active

Recruiting now

Completed

Stopped or withdrawn

Most-studied conditions

Non Small Cell Lung Cancer (NSCLC) · Multiple Myeloma · Breast Cancer · cMET-dysregulated Advanced Solid Tumors

Recently updated registry entries

NCT07114601 — A Study of LY4257496 in Participants With Cancer (OMNIRAY) (Recruiting)
NCT05755386 — Study of Efficacy and Safety of Iptacopan in Participants With IC-MPGN (Recruiting)
NCT06991556 — An Open-label Study of JSB462 (Luxdegalutamide) in Combination With Abiraterone in Adult… (Recruiting)

7 more recent registry entries at this facility

Enter your work email to view the full list.

I’d also like to receive occasional marketing emails from Eichor for research sites (optional — unsubscribe anytime).

Work at Emory University School of Medicine - Winship Cancer Institute?

Verify and correct how your facility appears in public registry records — free.

Verify this profile →

Compiled from public registry records (ClinicalTrials.gov) as of August 03, 2026. Counts reflect how this facility appears in registry listings; name variants may exist and are not combined. This page describes public records only and makes no assessment of any facility.